Community/Retail

The FDA recently approved Janssen's ustekinumab (Stelara) for the treatment of moderate to severe active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necrosis factor (TNF) blocker, as well as those who failed or were intolerant to treatment with one or more TNF blockers.

The U.S. Pharmacopeial Convention (USP) has posted for public comment its recommended revisions to the USP Medicare Model Guidelines (USP MMG) " a classification system that supports formulary development for medications covered under Medicare Part D benefits

In celebration of American Pharmacists Month, Walgreens is recognizing its more than 27,000 community pharmacists for their dedication to patient care, and the growing and important role they continue to play in health care today.

The National Community Pharmacists Association (NCPA) has written to the congressional committee that recently questioned the manufacturer of the EpiPen® about dramatic price hikes, and encouraged the panel's leaders to schedule a hearing examining pharmacy benefit manager (PBM) corporations at the center of prescription drug prices

This November, the National Association of Boards of Pharmacy is releasing a longer North American Pharmacist Licensure Examination.